Ocugen shares fall 1.87% premarket after U.S. court dismissed securities class action lawsuit.

Ocugen, Inc. declined 1.87% in premarket trading, following the news that a U.S. court granted the company's motion to dismiss a securities class action lawsuit. This legal victory is generally seen as a positive development for the company, but the stock's decline suggests that investors may be reacting to other factors or the news did not meet their expectations.